APT Medical Inc. (SHA: 688617)
China
· Delayed Price · Currency is CNY 370.42
+3.41 (0.93%)
Sep 6, 2024, 3:00 PM CST
APT Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | 619.09 | 533.92 | 358.02 | 207.92 | 110.78 | 82.57 | Upgrade
|
| Depreciation & Amortization | 74.73 | 64.01 | 48.26 | 33.44 | 20 | 14.68 | Upgrade
|
| Other Amortization | 4.31 | 3.88 | 3.22 | 1.11 | 0.74 | 0.65 | Upgrade
|
| Loss (Gain) From Sale of Assets | -10.76 | -10.81 | -0.06 | -0.02 | -0 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.52 | 3.97 | 10.68 | 3.57 | 0.24 | 0.35 | Upgrade
|
| Loss (Gain) From Sale of Investments | -15.83 | -23.13 | -21.09 | -32.82 | 0.07 | 1.01 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.96 | -0.18 | 0.79 | -0.51 | 0.28 | - | Upgrade
|
| Other Operating Activities | 7.76 | 0.91 | -13.45 | -3.88 | -5.13 | -3.85 | Upgrade
|
| Change in Accounts Receivable | -22.52 | 20 | -23.17 | 4.3 | 25.33 | -60.56 | Upgrade
|
| Change in Inventory | -25.57 | 11.22 | -72.59 | -124.21 | -2.44 | -62.74 | Upgrade
|
| Change in Accounts Payable | 55.99 | 68.9 | 61.71 | 82.51 | -0.48 | 80.98 | Upgrade
|
| Change in Other Net Operating Assets | 12.86 | 21.28 | 14.19 | 18.17 | -0.85 | 1.17 | Upgrade
|
| Operating Cash Flow | 701.22 | 689.06 | 367.46 | 181.39 | 148.24 | 54.9 | Upgrade
|
| Operating Cash Flow Growth | 35.14% | 87.52% | 102.58% | 22.36% | 170.03% | 194.66% | Upgrade
|
| Capital Expenditures | -584.52 | -202.03 | -143.21 | -167.38 | -44.2 | -67.56 | Upgrade
|
| Sale of Property, Plant & Equipment | 12.49 | 12.67 | 0.23 | 0.04 | 0.01 | 0.83 | Upgrade
|
| Cash Acquisitions | - | -46.37 | - | - | - | - | Upgrade
|
| Investment in Securities | 101.91 | 797.82 | -39.16 | -947.7 | -30 | -2 | Upgrade
|
| Other Investing Activities | 13.74 | 19.82 | 47.61 | 4.93 | 74.92 | 0.71 | Upgrade
|
| Investing Cash Flow | -456.38 | 581.9 | -134.53 | -1,110 | 0.73 | -68.02 | Upgrade
|
| Long-Term Debt Issued | - | 70 | 82.6 | 23.5 | 16.41 | 41.5 | Upgrade
|
| Long-Term Debt Repaid | - | -49.62 | -84.16 | -35.72 | -115.19 | -13.2 | Upgrade
|
| Net Debt Issued (Repaid) | -120.49 | 20.38 | -1.56 | -12.22 | -98.78 | 28.3 | Upgrade
|
| Issuance of Common Stock | 71.63 | 34.67 | - | 1,199 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -59.99 | - | - | - | Upgrade
|
| Common Dividends Paid | -1.08 | -112.22 | -69.01 | -33.19 | -1.41 | -5.97 | Upgrade
|
| Other Financing Activities | -189.18 | -189.18 | -164.04 | -34.54 | -1.43 | -25.57 | Upgrade
|
| Financing Cash Flow | -239.12 | -246.36 | -294.6 | 1,119 | -101.62 | -3.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.93 | 2.84 | 0.96 | -1.02 | -0.53 | -0.88 | Upgrade
|
| Net Cash Flow | 3.8 | 1,027 | -60.71 | 189.32 | 46.83 | -17.24 | Upgrade
|
| Free Cash Flow | 116.7 | 487.03 | 224.25 | 14.01 | 104.04 | -12.67 | Upgrade
|
| Free Cash Flow Growth | -66.81% | 117.18% | 1500.56% | -86.53% | - | - | Upgrade
|
| Free Cash Flow Margin | 6.26% | 29.51% | 18.44% | 1.69% | 21.70% | -3.14% | Upgrade
|
| Free Cash Flow Per Share | 1.20 | 4.98 | 2.29 | 0.15 | 1.44 | -0.17 | Upgrade
|
| Cash Income Tax Paid | 219.76 | 203.93 | 146.02 | 78.34 | 52.64 | 34.39 | Upgrade
|
| Levered Free Cash Flow | -80.94 | 354.02 | 263.62 | -35.72 | 39.73 | -49.51 | Upgrade
|
| Unlevered Free Cash Flow | -79.34 | 356.32 | 264.53 | -34.7 | 40.25 | -49.35 | Upgrade
|
| Change in Net Working Capital | -28.53 | -144.1 | -107.99 | 28.87 | 2.85 | 54.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.